TAIWAN · TWSE / TPEx
TABP
尖端醫 · 4186 · Emerging Stock Board · Biotech and medical
Share price, 2026-10-19NT$7.301 month +1.4% · 1 year -50.3%
Directors and supervisors hold15,913,35817.7% of shares issued
Of which pledged84.2%13,400,000
Major shareholders (10%+) hold11,039,60512.3% of shares issued
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 蘇文龍 | Chairman · President | 3,273,615 | 3,273,615 | 3.64% | 3,200,000 | 985,950 |
| 台灣醣聯生技醫藥股份有限公司 | Director | 763,471 | 763,471 | 0.85% | — | — |
| 吳蒂芬 | Director (corporate representative) | — | 0 | — | — | — |
| 信標生物科技股份有限公司 | Director · Major shareholder (10%+) | 11,039,605 | 11,039,605 | 12.27% | 10,200,000 | — |
| 陳耀聰 | Director (corporate representative) | — | 265,046 | 0.29% | — | 45,768 |
| 旭旺投資有限公司 | Director | 50,667 | 50,667 | 0.06% | — | — |
| 張耀仁 | Director (corporate representative) | — | 373,437 | 0.41% | — | — |
| 協菱股份有限公司 | Director | 285,000 | 285,000 | 0.32% | — | — |
| 楊友華 | Director (corporate representative) | — | 9,000 | 0.01% | — | — |
| 陳鈺霖 | Director · Assistant vice president | 1,000 | 1,000 | 0.00% | — | — |
| 劉駿宏 | Director | 500,000 | 500,000 | 0.56% | — | — |
| 封秋霞 | Independent director | — | 0 | — | — | — |
| 許文靜 | Independent director | — | 0 | — | — | — |
| 周秀原 | Independent director | — | 0 | — | — | — |
| 王灼杏 | Assistant vice president | — | 0 | — | — | — |
| 張莉玲 | Chief financial officer · Chief accountant | — | 13,495 | 0.01% | — | — |